$SOARJun 8, 2026, 10:15 AMAI processed

SOAR secures $2.2M investment led by VTAK and pivots toward AI infrastructure M&A

AI Summary

Volato Group (SOAR) signed a definitive agreement for a $2.2 million strategic investment of restricted common stock led by Catheter Precision (VTAK) to strengthen its balance sheet and fund a renewed AI-focused strategy targeting AI infrastructure, software, data, compute and power-generation assets. The announcement follows termination of a prior M2i transaction; Volato says it has received two unsolicited, non-binding LOIs for AI data-center and power-generation opportunities but no definitive agreements have been executed and the investment and any acquisitions remain subject to closing conditions and NYSE American listing authorization.

Positives

  • Signed definitive agreement for $2.2M strategic investment led by Catheter Precision (VTAK)
  • Management is refocusing on AI infrastructure and actively evaluating acquisition/merger opportunities, with two unsolicited LOIs reported
  • Company already owns Parslee AI software and is developing 'Volato AI', providing existing AI operating experience

Negatives

  • Investment is in restricted common stock and closing is subject to customary conditions including NYSE American supplemental listing authorization
  • Previously announced transaction with M2i Global was terminated
  • Reported LOIs are non-binding and there is no guarantee they will result in completed transactions; AI infra deals may require substantial capital and approvals